Clinical Trials Browser

NIH × Melanoma × Riluzole × Clear all

NCT01303341 2026-04-13

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

Phase 1 Active not recruiting

Melanoma